Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TYMP | P19971 | 1/20 | 0.44 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 2/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.38 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.38 |
| ▸ | P2RX6 | O15547 | 1/20 | 0.37 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.37 |
| ▸ | P2RX5 | Q93086 | 1/20 | 0.37 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | AHCY | P23526 | 1/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15445650 | 0.87 | PRMT6 (0.44) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL1798074 | 0.85 | LMNA (0.45) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL14508544 | 0.85 | LMNA (0.45) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL24539010 | 0.85 | LMNA (0.45) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL14534455 | 0.85 | LMNA (0.45) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL14586084 | 0.81 | ALDH1A1 (0.48) | LMNATYMPAHCY | |
| SCHEMBL24538795 | 0.80 | LMNA (0.45) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL16480856 | 0.80 | LMNA (0.46) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL4261195 | 0.80 | LMNA (0.44) | LMNATYMPP2RX3P2RX4P2RX2 | |
| SCHEMBL4270293 | 0.80 | LMNA (0.44) | LMNATYMPP2RX3P2RX4P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070032448-A1 | Sugar modified nucleosides as viral replication inhibitors | RIBAPHARM INC. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032448-A1 | Sugar modified nucleosides as viral replication inhibitors | PNP, MTAP, GALE | LMNA 4188/4885TYMP 16/4885P2RX3 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.